SullivanCotter and Lotis Blue Consulting Identify Competencies Defining the Future-Ready Health System CEO

CHICAGO–(BUSINESS WIRE)–#CEOSuccession—SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions, and data products for health care and not-for-profits, and its strategic partner Lotis Blue Consulting have released The Future-Ready Health System CEO: The Competencies and Attributes That Will Define Leadership in the Next Era of Health … [Read more…]

Hims & Hers Now Serving Customers in Canada

Follows strategic acquisition of Livewell, a trusted Canadian digital health platform for weight loss care MONTREAL–(BUSINESS WIRE)–Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent acquisition of Livewell, a trusted Canadian digital health platform focused on … [Read more…]

LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-driven Antibody Optimisation Programmes

The companies have entered into a new collaboration where LabGenius Therapeutics will apply its ML-driven antibody discovery platform (EVA™) to optimise potential therapeutic NANOBODY® proteins for multiple new targets LONDON–(BUSINESS WIRE)–#AI—LabGenius Therapeutics (“LabGenius”), a drug discovery company combining machine learning (ML) and high-throughput experimentation to optimise potential therapeutic antibodies, today announced a second collaboration with … [Read more…]

Galderma Secures ‘BBB’ Credit Rating With Positive Outlook from S&P Global Ratings

‘BBB’ long-term issuer credit rating from S&P Global Ratings Positive outlook, reflecting expected profitability improvement, ramp up of Nemluvio, and continued deleveraging and balance sheet improvement Recognition of Galderma’s science-based dermatology portfolio and global operations ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that S&P Global Ratings (S&P) has assigned … [Read more…]

Incredible Health Reaches 1.5 Million Nurses as AI Voice Agents Drive Record Growth

SAN FRANCISCO–(BUSINESS WIRE)–Incredible Health, the largest AI company powering healthcare hiring, today announced it has reached 1.5 million nurses on its career marketplace, representing half of active nurses in the United States. The company now serves more than 1,500 US healthcare employers. Eight weeks ago, Incredible Health introduced Gale and Lyn, two purpose-built AI voice … [Read more…]

Swisslog Healthcare to Showcase New Tenutō™ Line at Conference for Pharmacists

Advancing cold chain technology with enhanced medication safety and energy efficiency BROOMFIELD, Colo.–(BUSINESS WIRE)–Swisslog Healthcare, a leading supplier in transport and pharmacy automation solutions, will showcase Tenutō Medical Refrigerators and Freezers at the American Society of Health-System Pharmacists Midyear Conference from December 7-10. This launch introduces cutting-edge cold chain technology designed to enhance patient safety … [Read more…]

Align Technology Showcases Digital Dentistry Innovations at Greater New York Dental Meeting 2025

Booth presentations and clinical education sessions highlighted Align™ Digital Platform innovations to empower dental professionals and advance Invisalign® treatment experiences TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software, today shared highlights from … [Read more…]

RSNA25: Pediatric Study for Bayer’s Investigational MRI Contrast Agent Gadoquatrane Meets Primary and Secondary Endpoints

Bayer revealed first results of the pediatric study from the pivotal clinical development program QUANTI for its low-dose MRI contrast agent QUANTI Pediatric evaluated the pharmacokinetics and safety of gadoquatrane in children (birth to <18) at a gadolinium dose of 0.04 mmol Gd/kg body weight, representing a dose reduction of 60 percent compared to the … [Read more…]

Catalyst OrthoScience Receives FDA 510(k) Clearance for Expanded Indications of the Fracture Shoulder System

New indications expand applications for Catalyst Fracture System to anatomic shoulder restorations NAPLES, Fla.–(BUSINESS WIRE)–Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology company redefining shoulder arthroplasty through simplified, surgeon-focused innovation, today announced that its Catalyst Fracture Shoulder System has received FDA 510(k) clearance for additional indications that now include anatomic (total or hemi) shoulder procedures, … [Read more…]

Federal Circuit Court of Appeals Vacates Infringement Judgment and Damages Award in Dispute between Daiichi Sankyo and Seagen

TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–On December 2, the U.S. Court of Appeals for the Federal Circuit (the Federal Circuit) reversed a decision from the U.S. District Court for the Eastern District of Texas that found Seagen Inc’s U.S. Patent No. 10,808,039 (the ’039 patent) not invalid (the Texas decision). In view of the reversal, … [Read more…]